Successful completion of the Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) trial, reported in this issue of Cancer Discovery, is an important advance in the effort to improve clinical trial approaches to the simultaneous development of new therapeutics with matching diagnostic tests so that patients most likely to benefit from these therapies can be identified.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1158/2159-8274.CD-11-0036 | DOI Listing |
Publication Analysis
Top Keywords
battle trial
8
trial bold
4
bold step
4
step improving
4
improving efficiency
4
efficiency biomarker-based
4
biomarker-based drug
4
drug development
4
development successful
4
successful completion
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!